Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2014 Filed Jul 1, 2014 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 243.03 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-14-027221 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857.36 Underlying: Common Stock · 243.03 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of June 28, 2014, at a price of $118.30 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 28, 2014, at a price of $118.30 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 28, 2014, at a price of $118.30 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| June 11, 2014 Filed Aug 28, 2014 23:32 UTC |
Malus Alan JExecutive Vice President
|
GiftCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-026759 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,959 Read SEC document |
| June 11, 2014 Filed Feb 13, 2015 22:04 UTC |
ULLIAN ELAINEDirector
|
GiftCommon Stock | 4,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-006063 · form5.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,914 Read SEC document |
| June 04, 2014 Filed Jun 5, 2014 20:34 UTC |
HARRIS C MARTINDirector
|
SaleCommon Stock | 810 | $118.27 | $95,798.70 |
DisclosureSEC source: 0001127602-14-020016 · form4.xml · nonDerivative · entry 1 HARRIS C MARTIN · CIK 0001236982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,432 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:48 UTC |
Chai NelsonDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018482 · form4.xml · nonDerivative · entry 1 Chai Nelson · CIK 0001299914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,450 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:51 UTC |
HARRIS C MARTINDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018485 · form4.xml · nonDerivative · entry 1 HARRIS C MARTIN · CIK 0001236982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,242 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:53 UTC |
Jacks TylerDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018486 · form4.xml · nonDerivative · entry 1 Jacks Tyler · CIK 0001464237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,550 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:55 UTC |
LEWENT JUDY CDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018488 · form4.xml · nonDerivative · entry 1 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,499 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:57 UTC |
LYNCH THOMAS JDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018489 · form4.xml · nonDerivative · entry 1 LYNCH THOMAS J · CIK 0001208323 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,959 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:58 UTC |
MANZI JIM PDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018490 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,308 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:59 UTC |
Parrett William GDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018491 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,499 Read SEC document |
| May 20, 2014 Filed May 22, 2014 21:00 UTC |
SORENSEN LARS REBIENDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018493 · form4.xml · nonDerivative · entry 2 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,905 Read SEC document |
| May 20, 2014 Filed May 22, 2014 21:00 UTC |
SORENSEN LARS REBIENDirector
|
Tax withholdingCommon Stock | 522 | $114.47 | $59,753.34 |
DisclosureSEC source: 0001127602-14-018493 · form4.xml · nonDerivative · entry 1 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,594 Read SEC document |
| May 20, 2014 Filed May 22, 2014 21:02 UTC |
ULLIAN ELAINEDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-018494 · form4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,159 Read SEC document |
| May 20, 2014 Filed May 22, 2014 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-14-022669 · doc1.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,414 Read SEC document |
| April 29, 2014 Filed Apr 30, 2014 20:40 UTC |
MANZI JIM PDirector
|
SaleCommon Stock | 3,000 | $114.85 | $344,550.00 |
DisclosureSEC source: 0001127602-14-015631 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.78 to $114.90, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2014 Filed Apr 29, 2014 20:39 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,625 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-015470 · form4.xml · derivative · entry 5 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,625 Underlying: Common Stock · 3,625 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013, and 2014, and the last installment becomes exercisable on March 5, 2015. Read SEC document |
| April 28, 2014 Filed Apr 29, 2014 20:39 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,063 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-015470 · form4.xml · derivative · entry 4 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,063 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four equal installments on March 5, 2011, 2012, 2013 and 2014. Read SEC document |
| April 28, 2014 Filed Apr 29, 2014 20:39 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 8,688 | $114.49 | $994,689.12 |
DisclosureSEC source: 0001127602-14-015470 · form4.xml · nonDerivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,307 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.46 to $114.55, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2014 Filed Apr 29, 2014 20:39 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 3,625 | $49.49 | $179,401.25 |
DisclosureSEC source: 0001127602-14-015470 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2014 Filed Apr 29, 2014 20:39 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 5,063 | $49.49 | $250,567.87 |
DisclosureSEC source: 0001127602-14-015470 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2014 Filed Apr 1, 2014 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 242.62 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-14-015105 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,614.33 Underlying: Common Stock · 242.62 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of March 29, 2014, at a price of $118.50 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of March 29, 2014, at a price of $118.50 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of March 29, 2014, at a price of $118.50 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,750 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · derivative · entry 9 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Common Stock · 21,750 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013 and 2014, and the next installment becomes exercisable on March 5, 2015. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 53,300 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · derivative · entry 8 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,300 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested in four equal annual installments on March 5, 2011, 2012, 2013 and 2014. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 200 | $123.51 | $24,702.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 7 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,030 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.50 to 123.52, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 11,000 | $122.89 | $1,351,790.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 6 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.47 to 123.42, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 8,662 | $121.78 | $1,054,858.36 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 5 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.35 to 122.31, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 25,745 | $120.73 | $3,108,193.85 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,892 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.35 to 121.33, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 34,437 | $119.80 | $4,125,552.60 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,637 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.40 to $120.32, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 21,750 | $49.49 | $1,076,407.50 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 53,300 | $49.49 | $2,637,817.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:17 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 100 | $126.58 | $12,658.00 |
DisclosureSEC source: 0001127602-14-011336 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,307 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:17 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 5,141 | $125.89 | $647,200.49 |
DisclosureSEC source: 0001127602-14-011336 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.43 to $126.39, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · derivative · entry 9 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,100 Underlying: Common Stock · 15,000 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013 and 2014, and the next installment becomes exercisable on February 23, 2015. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,625 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · derivative · entry 8 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,625 Underlying: Common Stock · 3,625 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013 and 2014, and the next installment becomes exercisable on March 5, 2015. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,075 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · derivative · entry 7 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,075 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in four equal annual installments on March 5, 2011, 2012, 2013 and 2014. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 2,516 | $126.44 | $318,123.04 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · nonDerivative · entry 5 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,595 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.40 to $126.69, inclusive. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 27,658 | $126.05 | $3,486,290.90 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · nonDerivative · entry 4 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,111 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.37 to $126.35, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 15,000 | $54.97 | $824,550.00 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · nonDerivative · entry 3 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 3,625 | $49.49 | $179,401.25 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2014 Filed Mar 12, 2014 21:19 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 6,075 | $49.49 | $300,651.75 |
DisclosureSEC source: 0001127602-14-011338 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:12 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 1,559 | $125.91 | $196,293.69 |
DisclosureSEC source: 0001127602-14-010734 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,414 Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:14 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 1,621 | $125.91 | $204,100.11 |
DisclosureSEC source: 0001127602-14-010735 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,024 Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:19 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 1,621 | $125.91 | $204,100.11 |
DisclosureSEC source: 0001127602-14-010743 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,359 Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:23 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 744 | $125.91 | $93,677.04 |
DisclosureSEC source: 0001127602-14-010745 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,069 Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:21 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 203 | $125.91 | $25,559.73 |
DisclosureSEC source: 0001127602-14-010744 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,141 Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 21:30 UTC |
SPERLING SCOTT MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001140361-14-011673 · doc1.xml · derivative · entry 3 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2014-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 21:30 UTC |
SPERLING SCOTT MDirector
|
SaleCommon Stock | 4,550 | $125.92 | $572,936.00 |
DisclosureSEC source: 0001140361-14-011673 · doc1.xml · nonDerivative · entry 2 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,103 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.91 to $125.93, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Secruities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the rage set forth in this footnote. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 21:30 UTC |
SPERLING SCOTT MDirector
|
Exercise / conversionCommon Stock | 20,000 | $28.68 | $573,600.00 |
DisclosureSEC source: 0001140361-14-011673 · doc1.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 21:56 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 5,054 | $124.54 | $629,425.16 |
DisclosureSEC source: 0001127602-14-010000 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,973 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.